Lipid Based Nanoparticles as Inherent Reversing Agents of Multidrug Resistance in Cancer

E-ISSN： 1873-4286|23|43|6714-6729

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.43, 2018-02, pp. : 6714-6729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells

Current Cancer Drug Targets, Vol. 9, Iss. 3, 2009-05 ,pp. : 298-306

Bentham Science Publishers

Access to resources Recommend Favorite

1-Benzyl-1,2,3,4-tetrahydroisoquinoline Derivatives and Optically Pure Isomers as Novel Promising Multidrug Resistance (MDR) Reversing Agents

Letters in Drug Design & Discovery, Vol. 6, Iss. 5, 2009-07 ,pp. : 387-392

Bentham Science Publishers

Access to resources Recommend Favorite

ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy

Current Drug Targets, Vol. 16, Iss. 12, 2015-10 ,pp. : 1356-1371

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-drug resistance and cancer

By Atalay Can

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 511-520

Informa Healthcare

Access to resources Recommend Favorite

New Multidrug Resistance Reversal Agents

Current Drug Targets, Vol. 4, Iss. 1, 2003-01 ,pp. : 31-43

Bentham Science Publishers

Access to resources Recommend Favorite